NCCN VERSION 2 2015

151 / 188

Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®. MS-76
NCCN Guidelines Index
Breast Cancer Table of Contents
Discussion
NCCN Guidelines Version 2.2015
Breast Cancer
2001;67:513-519. Available at:
.
130. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast
cancer--a multicenter validation study. N Engl J Med 1998;339:941-946.
Available at:
131. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node
resection compared with conventional axillary-lymph-node dissection in
clinically node-negative patients with breast cancer: overall survival
findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol
2010;11:927-933. Available at:
.
132. Kuehn T, Vogl FD, Helms G, et al. Sentinel-node biopsy for axillary
staging in breast cancer: results from a large prospective German multi-
institutional trial. Eur J Surg Oncol 2004;30:252-259. Available at:
.
133. McMasters KM, Giuliano AE, Ross MI, et al. Sentinel-lymph-node
biopsy for breast cancer--not yet the standard of care. N Engl J Med
1998;339:990-995. Available at:
134. O'Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node
biopsy in breast cancer: initial experience at Memorial Sloan-Kettering
Cancer Center. J Am Coll Surg 1998;186:423-427. Available at:
135. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison
of sentinel-node biopsy with routine axillary dissection in breast cancer.
N Engl J Med 2003;349:546-553. Available at:
.
136. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter
trial of sentinel node biopsy versus standard axillary treatment in
operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst
2006;98:599-609. Available at:
.
137. Cox CE, Salud CJ, Cantor A, et al. Learning curves for breast
cancer sentinel lymph node mapping based on surgical volume
analysis. J Am Coll Surg 2001;193:593-600. Available at:
.
138. Dupont E, Cox C, Shivers S, et al. Learning curves and breast
cancer lymphatic mapping: institutional volume index. J Surg Res
2001;97:92-96. Available at:
.
139. Giuliano AE, Hawes D, Ballman KV, et al. Association of occult
metastases in sentinel lymph nodes and bone marrow with survival
among women with early-stage invasive breast cancer. JAMA
2011;306:385-393. Available at:
.
140. Degnim AC, Reynolds C, Pantvaidya G, et al. Nonsentinel node
metastasis in breast cancer patients: assessment of an existing and a
new predictive nomogram. Am J Surg 2005;190:543-550. Available at:
.
141. Houvenaeghel G, Nos C, Giard S, et al. A nomogram predictive of
non-sentinel lymph node involvement in breast cancer patients with a
sentinel lymph node micrometastasis. Eur J Surg Oncol 2009;35:690-
695. Available at:
142. Katz A, Smith BL, Golshan M, et al. Nomogram for the prediction
of having four or more involved nodes for sentinel lymph node-positive
breast cancer. J Clin Oncol 2008;26:2093-2098. Available at:
.
143. Kohrt HE, Olshen RA, Bermas HR, et al. New models and online
calculator for predicting non-sentinel lymph node status in sentinel
lymph node positive breast cancer patients. BMC Cancer 2008;8:66-66.
Available at: .